Home/Filings/4/0000899243-21-006354
4//SEC Filing

Millar Kerri-Ann 4

Accession 0000899243-21-006354

CIK 0001645460other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 5:43 PM ET

Size

5.3 KB

Accession

0000899243-21-006354

Insider Transaction Report

Form 4
Period: 2021-02-10
Millar Kerri-Ann
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Stock Option (right to buy)

    2021-02-10+70,00070,000 total
    Exercise: $15.55Exp: 2031-02-09Common Stock (70,000 underlying)
Footnotes (1)
  • [F1]This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 10, 2021.

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1
  • filerCIK 0001739126

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:43 PM ET
Size
5.3 KB